Loading...
Loading...
SLGCW| Name | Value |
|---|---|
| Revenues | 20.4M |
| Cost of Revenue | 12.3M |
| Gross Profit | 8.1M |
| Operating Expense | 48.3M |
| Operating I/L | -40.2M |
| Other Income/Expense | 6.0M |
| Interest Income | 4.9M |
| Pretax | -34.2M |
| Income Tax Expense | 0.0M |
| Net Income/Loss | -34.2M |
SomaLogic, Inc. is a protein biomarker discovery and clinical diagnostics company that develops slow off-rate modified aptamers (SOMAmers) and offers SomaScan services for multiplex protein detection and quantification in biological samples. Its SOMAmers/SomaScan technology enables researchers to analyze samples for protein biomarker signatures, aiding drug discovery and development. The company's biomarker discoveries have applications in cardiovascular and metabolic disease, nonalcoholic steatohepatitis, wellness, and more. SomaLogic also provides SomaSignal research use only and laboratory-developed tests, serving pharmaceutical and biotechnology companies, academic research institutions, and facilitating drug development, clinical trial analysis, and new human biology insights.
